These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Biochemical isolation of insoluble tau in transgenic mouse models of tauopathies. Julien C, Bretteville A, Planel E. Methods Mol Biol; 2012; 849():473-91. PubMed ID: 22528110 [Abstract] [Full Text] [Related]
34. The CNS in inbred transgenic models of 4-repeat Tauopathy develops consistent tau seeding capacity yet focal and diverse patterns of protein deposition. Eskandari-Sedighi G, Daude N, Gapeshina H, Sanders DW, Kamali-Jamil R, Yang J, Shi B, Wille H, Ghetti B, Diamond MI, Janus C, Westaway D. Mol Neurodegener; 2017 Oct 04; 12(1):72. PubMed ID: 28978354 [Abstract] [Full Text] [Related]
35. Characteristics of TBS-extractable hyperphosphorylated tau species: aggregation intermediates in rTg4510 mouse brain. Sahara N, DeTure M, Ren Y, Ebrahim AS, Kang D, Knight J, Volbracht C, Pedersen JT, Dickson DW, Yen SH, Lewis J. J Alzheimers Dis; 2013 Oct 04; 33(1):249-63. PubMed ID: 22941973 [Abstract] [Full Text] [Related]
37. Immunoelectron microscopic and biochemical studies of caspase-cleaved tau in a mouse model of tauopathy. Lin WL, Dickson DW, Sahara N. J Neuropathol Exp Neurol; 2011 Sep 04; 70(9):779-87. PubMed ID: 21865886 [Abstract] [Full Text] [Related]